On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Peter H. O’Donnell

ResearcherPublications, citations & collaboration network

Peter H. O’Donnell is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Peter H. O’Donnell have?

ScholarIQindexed works

Peter H. O’Donnell has 337 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Peter H. O’Donnell have?

ScholarIQcitation count

Peter H. O’Donnell has 30,989 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Peter H. O’Donnell?

ScholarIQh-index

Peter H. O’Donnell has an h-index of 52 in OpenAlex.

What is the i10-index of Peter H. O’Donnell?

ScholarIQi10-index

Peter H. O’Donnell has an i10-index of 142 in OpenAlex.

What is the ORCID of Peter H. O’Donnell?

ScholarIQorcid

The ORCID for Peter H. O’Donnell is on the source record.

What is the OpenAlex record for Peter H. O’Donnell?

ScholarIQopenalex

The OpenAlex for Peter H. O’Donnell is on the source record.

What are the most-cited papers on Peter H. O’Donnell?

ScholarIQmost cited works
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
The Lancet. 20163,735 Citations
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, Jan W. Eriksson, Simon Heller, Ole Hels, Richard E. Pratley, Thozhukat Sathyapalan, Cyrus Desouza, R.N. Abramof, Diana N Alpenidze, S Aronoff, K. Astamirova, B Barker, Gary Bedel, Lidia Belousova, Mark D. Benson, Isaac Beshay, William Biggs, Kenneth Blaze, Paweł Bogdański, Robert S. Busch, Sushela Chaidarun, Siddharthan Chandran, Alex R. Chang, S Chilka, Alan S. Cleland, Lisa Connery, George Mitchell Cornett, Bruno Delgado, Cyrus Desouza, Thomas Donner, Ken Eliasson, Jan W. Eriksson, Steven Folkerth, Kristy Forshaw, Hans Frandsen, Elena Frolova, Winston Gandy, G Gatipon, Albina Golovach, L. Gonzalez-Orozco, Janusz Gumprecht, Élie Haddad, Troels Krarup Hansen, Thomas C. Hart, Syed Shahzad Hasan, Brent Hella, Simon Heller, Margareta Hellgren, Mark I. Hewitt, S Hietaniemi, Marc‐Phillip Hitz, P Houser, Raphael E. Huntley, R. A. JACKSON, Poul Erik Jakobsen, Anuj Pal Kapoor, L. Kargina, Elena Kazakova, Khalid Khan, E. Klein, H Knoble, N Krasnopeeva, Andre Krzeminski, М. А. Куницына, J Lawhead, Klaus Levin, Philip Levin, Lorena Lewy-Alterbaum, Stina Lindmark, Robert S. Lindsay, Alain Luts, Tatyana Lysenko, Sten Madsbad, Tyler Maxwell, Caroline Mbogua, JA McKnight, Kaj Metsärinne, Т. А. Милованова, Emily Morawski, Ofri Mosenzon, Dan Nabriski, Hai Quy Tram Nguyen, Philip Nicol, Sanna Nieminen, Anita Schwab Nikkola, Paul Norwood, Peter H. O’Donnell, A. Ola Odugbesan, Jeremy C. Parker, Y. Pergaeva, А. Б. Песков, S. Plevin, Joe Pouzar, Richard E. Pratley, Josh Reed, Peter Rossing, Thozhukat Sathyapalan, M. Sergeeva-Kondrachenko
The Lancet Diabetes & Endocrinology. 2019345 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account